Back to top

Image: Bigstock

Is USANA Health Sciences (USNA) a Great Value Stock Right Now?

Read MoreHide Full Article

While the proven Zacks Rank places an emphasis on earnings estimates and estimate revisions to find strong stocks, we also know that investors tend to develop their own individual strategies. With this in mind, we are always looking at value, growth, and momentum trends to discover great companies.

Considering these trends, value investing is clearly one of the most preferred ways to find strong stocks in any type of market. Value investors use a variety of methods, including tried-and-true valuation metrics, to find these stocks.

Zacks has developed the innovative Style Scores system to highlight stocks with specific traits. For example, value investors will be interested in stocks with great grades in the "Value" category. When paired with a high Zacks Rank, "A" grades in the Value category are among the strongest value stocks on the market today.

One company value investors might notice is USANA Health Sciences (USNA - Free Report) . USNA is currently sporting a Zacks Rank #2 (Buy), as well as a Value grade of A.

We also note that USNA holds a PEG ratio of 0.81. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. USNA's PEG compares to its industry's average PEG of 1.84. Over the past 52 weeks, USNA's PEG has been as high as 1.39 and as low as 0.65, with a median of 0.87.

Investors should also recognize that USNA has a P/B ratio of 1.08. The P/B is a method of comparing a stock's market value to its book value, which is defined as total assets minus total liabilities. This stock's P/B looks solid versus its industry's average P/B of 1.68. Within the past 52 weeks, USNA's P/B has been as high as 1.49 and as low as 0.83, with a median of 1.13.

Finally, we should also recognize that USNA has a P/CF ratio of 8.75. This figure highlights a company's operating cash flow and can be used to find firms that are undervalued when considering their impressive cash outlook. USNA's P/CF compares to its industry's average P/CF of 13.01. Within the past 12 months, USNA's P/CF has been as high as 10.82 and as low as 7.18, with a median of 9.19.

These figures are just a handful of the metrics value investors tend to look at, but they help show that USANA Health Sciences is likely being undervalued right now. Considering this, as well as the strength of its earnings outlook, USNA feels like a great value stock at the moment.


See More Zacks Research for These Tickers


Normally $25 each - click below to receive one report FREE:


USANA Health Sciences, Inc. (USNA) - free report >>

Published in